A cancer pharmacogenomic screen powering crowd-sourced advancement of drug combination prediction
Preprint
- 9 October 2017
- preprint
- other
- Published by Cold Spring Harbor Laboratory
- p. 200451
- https://doi.org/10.1101/200451
Abstract
The effectiveness of most cancer targeted therapies is short lived since tumors evolve and develop resistance. Combinations of drugs offer the potential to overcome resistance, however the number of possible combinations is vast necessitating data-driven approaches to find optimal treatments tailored to a patient’s tumor. AstraZeneca carried out 11,576 experiments on 910 drug combinations across 85 cancer cell lines, recapitulating in vivo response profiles. These data, the largest openly available screen, were hosted by DREAM alongside deep molecular characterization from the Sanger Institute for a Challenge to computationally predict synergistic drug pairs and associated biomarkers. 160 teams participated to provide the most comprehensive methodological development and subsequent benchmarking to date. Winning methods incorporated prior knowledge of putative drug target interactions. For >60% of drug combinations synergy was reproducibly predicted with an accuracy matching biological replicate experiments, however 20% of drug combinations were poorly predicted by all methods. Genomic rationale for synergy predictions were identified, including antagonism unique to combined PIK3CB/D inhibition with the ADAM17 inhibitor where synergy is seen with other PI3K pathway inhibitors. All data, methods and code are freely available as a resource to the community.Keywords
Other Versions
- Published version: Version Nature Communications, 10, preprints
This publication has 43 references indexed in Scilit:
- Network quantification of EGFR signaling unveils potential for targeted combination therapyMolecular Systems Biology, 2013
- Wisdom of crowds for robust gene network inferenceNature Methods, 2012
- The landscape of cancer genes and mutational processes in breast cancerNature, 2012
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate CancerCancer Cell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysisBMC Bioinformatics, 2010
- A human B‐cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centersMolecular Systems Biology, 2010
- PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer dataBiostatistics, 2009
- Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short readsBioinformatics, 2009
- Androgen receptor and growth factor signaling cross-talk in prostate cancer cellsEndocrine-Related Cancer, 2008